Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows

Huebner, H. et al. Filtration based assessment of CTCs and Cell Search® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients. BMC

Cancer 18, 204. https://doi.org/10.1186/s12885-018-4115-1 (2018).Article  Google Scholar  Banys-Paluchowski, M., Krawczyk, N. & Fehm, T. Liquid biopsy in breast cancer.

Geburtshilfe Frauenheilkd 80, 1093–1104. https://doi.org/10.1055/a-1124-7225 (2020).Article  Google Scholar  Grabuschnig, S. et al. Putative origins of cell-free DNA in humans:

A review of active and passive nucleic acid release mechanisms. Int. J. Mol. Sci. 21, 8062. https://doi.org/10.3390/ijms21218062 (2020).Article  Google Scholar  Ulz, P. et al.

Inferring expressed genes by whole-genome sequencing of plasma DNA. Nat. Genet. 48, 1273–1278. https://doi.org/10.1038/ng.3648 (2016).Article  Google Scholar  Polasik, A. et

al. Circulating tumour cells, circulating tumour DNA and circulating MicroRNA in metastatic breast carcinoma—What is the role of liquid biopsy in breast cancer?. Geburtshilfe

Frauenheilkd 77, 1291–1298. https://doi.org/10.1055/s-0043-122884 (2017).Article  Google Scholar  Uehiro, N. et al. Circulating cell-free DNA-based epigenetic assay can detect

early breast cancer. Breast Cancer Res. 18, 129. https://doi.org/10.1186/s13058-016-0788-z (2016).Article  Google Scholar  Arko-Boham, B. et al. Circulating cell-free DNA

integrity as a diagnostic and prognostic marker for breast and prostate cancers. Cancer Genet. 235–236, 65–71. https://doi.org/10.1016/j.cancergen.2019.04.062 (2019).Article 

Google Scholar  Stötzer, O. J., Lehner, J., Fersching-Gierlich, D., Nagel, D. & Holdenrieder, S. Diagnostic relevance of plasma DNA and DNA integrity for breast cancer.

Tumour Biol. 35, 1183–1191. https://doi.org/10.1007/s13277-013-1158-4 (2014).Article  Google Scholar  Hussein, N. A., Mohamed, S. N. & Ahmed, M. A. Plasma ALU-247, ALU-115,

and cfDNA integrity as diagnostic and prognostic biomarkers for breast cancer. Appl. Biochem. Biotechnol. 187, 1028–1045. https://doi.org/10.1007/s12010-018-2858-4

(2019).Article  Google Scholar  Garcia-Murillas, I. et al. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci. Transl. Med. 7, 302ra133.

https://doi.org/10.1126/scitranslmed.aab0021 (2015).Article  Google Scholar  Olsson, E. et al. Serial monitoring of circulating tumor DNA in patients with primary breast cancer

for detection of occult metastatic disease. EMBO Mol. Med. 7, 1034–1047. https://doi.org/10.15252/emmm.201404913 (2015).Article  Google Scholar  Chandarlapaty, S. et al.